Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Sweden
/
Bengt Erik Dahlström
BE
Bengt Erik Dahlström
Board of Directors, PMC Clinical Research Aktiebolag
Sveavägen 8
SE
10 active roles
Watchlist
Share
Overview
Companies & roles
Network
Loading profile…
Companies & roles
Active roles
10 positions
Company
Role
Period
Ownership
Status
PMC Clinical Research Aktiebolag
CVR 5562882810
Board
Board of Directors
Since 2023
—
Dissolved
PMC Analytical Services Aktiebolag
CVR 5562940824
Board
Board of Directors
Since 2023
—
Dissolved
Aktiebolaget Biopharmacon
CVR 5563302453
Board
Board of Directors
Since 2021
—
Active
PMC Drug Study Unit Aktiebolag
CVR 5563302529
Board
Board of Directors
Since 2023
—
Dissolved
UppInvest in Sweden AB
CVR 5565428983
Board
Board of Directors
Since 2023
—
Dissolved
Epimeleia AB
CVR 5590345582
Board
Board of Directors
Since 2022
—
Active
Center for Translational Research Sweden AB
CVR 5590544903
Board
Board of Directors
Since 2021
—
Active
RegFile AB
CVR 5592398928
Board
Deputy Board Member
Since 2025
—
Active
UppuCare AB
CVR 5593683831
Board
Board of Directors
Since 2022
—
Active
QAlliance AB
CVR 5594366436
Board
Board of Directors
Since 2023
—
Active
Historical roles
7 positions
Company
Role
Period
Ownership
Status
Zelmic AB
CVR 5567737738
Board
Board of Directors
2024 – 2026
—
Active
CTC Clinical Trial Consultants AB
CVR 5568491848
Board
Board of Directors
2022 – 2026
—
Active
Toxicology Knowledge Team Sweden AB
CVR 5569024614
Board
Board of Directors
2020 – 2026
—
Active
Metasafe Sweden AB
CVR 5591028666
Board
Board of Directors
2022 – 2022
—
Active
RegSmart Life Science AB
CVR 5592005382
Board
Board of Directors
2022 – 2026
—
Active
Lablytica Life Science AB
CVR 5592179088
Board
Board of Directors
2022 – 2026
—
Active
CTR Translational Next AB
CVR 5592398936
Board
Board of Directors
2022 – 2025
—
Dissolved
1 dissolved company in directorship history
CTR Translational Next AB
CVR 5592398936 · Dissolved 2025 · —
Role: Board of Directors
More on Bengt Erik Dahlström
Overview →
Headline figures, risk signals and profile summary
Network →
Connections across other directors and entities